Trademark Attorney / Law Firm
Christina Demory – Trademark Portfolio
Christina Demory specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 6 of 9 total filings concentrated in this category. The practice also covers Class 41 (Education & Entertainment) along with 3 other Nice Classification classes. Filing activity spans from 2014 to 2018. Currently, 2 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Christina Demory's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademark applications has Christina Demory filed?
Christina Demory has filed 9 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 2 registered, 4 abandoned, 3 cancelled.
What trademark classes does Christina Demory specialize in?
Christina Demory has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has Christina Demory been filing trademarks?
Christina Demory's trademark filing history with the USPTO spans from 2014 to 2018, covering 4 years of trademark practice. During this period, Christina Demory has handled 9 trademark applications.
What is Christina Demory's trademark registration success rate?
Christina Demory has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.